Brief and cost-effective tool for assessing verbal learning in multiple sclerosis

Comparison of the Rey Auditory Verbal Learning Test (RAVLT) to the California Verbal Learning Test – II (CVLT-II)

Meghan Beier, Abbey Hughes, Michael W. Williams, Elizabeth S. Gromisch

Research output: Contribution to journalArticle

Abstract

Background: The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is a common cognitive screening tool. However, administration and scoring can be time-consuming, and its use of proprietary subtests like the California Verbal Learning Test – II (CVLT-II) is financially limiting. Use of the non-proprietary Rey Auditory Verbal Learning Test (RAVLT) may be provide a valid alternative. Objectives: To compare the RAVLT and CVLT-II in terms of diagnostic accuracy for detecting cognitive impairment, and to determine optimal cut-scores for the RAVLT. Methods: 100 participants with MS completed the five learning trials from the RAVLT and CVLT-II. Receiver operating characteristic analyses were used to compare the measures’ sensitivities, specificities, positive predictive values (PPV) and negative predictive values (NPV), and to identify optimal cut-scores. Results: Using a criterion of 1.5 SD below the normative sample mean, the RAVLT showed fair to good (κs = 0.21–0.41) agreement with the CVLT-II. A cut-score of 12 on Trials 1 + 2 of the RAVLT showed fair sensitivity (75%) and specificity (76%) and did not differ significantly from the CVLT-II (p >.05). Conclusions: Performance on initial learning trials of the RAVLT may provide a brief, valid, and cost-effective alternative to the CVLT-II for screening verbal learning impairments in MS.

Original languageEnglish (US)
Pages (from-to)104-109
Number of pages6
JournalJournal of the Neurological Sciences
Volume400
DOIs
StatePublished - May 15 2019

Fingerprint

Verbal Learning
Multiple Sclerosis
Costs and Cost Analysis
Learning
Sensitivity and Specificity
ROC Curve

Keywords

  • Cognitive dysfunction
  • Cut scores
  • Multiple sclerosis
  • Neuropsychological tests

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

@article{5fff7c67d38044929735da26d72a629c,
title = "Brief and cost-effective tool for assessing verbal learning in multiple sclerosis: Comparison of the Rey Auditory Verbal Learning Test (RAVLT) to the California Verbal Learning Test – II (CVLT-II)",
abstract = "Background: The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is a common cognitive screening tool. However, administration and scoring can be time-consuming, and its use of proprietary subtests like the California Verbal Learning Test – II (CVLT-II) is financially limiting. Use of the non-proprietary Rey Auditory Verbal Learning Test (RAVLT) may be provide a valid alternative. Objectives: To compare the RAVLT and CVLT-II in terms of diagnostic accuracy for detecting cognitive impairment, and to determine optimal cut-scores for the RAVLT. Methods: 100 participants with MS completed the five learning trials from the RAVLT and CVLT-II. Receiver operating characteristic analyses were used to compare the measures’ sensitivities, specificities, positive predictive values (PPV) and negative predictive values (NPV), and to identify optimal cut-scores. Results: Using a criterion of 1.5 SD below the normative sample mean, the RAVLT showed fair to good (κs = 0.21–0.41) agreement with the CVLT-II. A cut-score of 12 on Trials 1 + 2 of the RAVLT showed fair sensitivity (75{\%}) and specificity (76{\%}) and did not differ significantly from the CVLT-II (p >.05). Conclusions: Performance on initial learning trials of the RAVLT may provide a brief, valid, and cost-effective alternative to the CVLT-II for screening verbal learning impairments in MS.",
keywords = "Cognitive dysfunction, Cut scores, Multiple sclerosis, Neuropsychological tests",
author = "Meghan Beier and Abbey Hughes and Williams, {Michael W.} and Gromisch, {Elizabeth S.}",
year = "2019",
month = "5",
day = "15",
doi = "10.1016/j.jns.2019.03.016",
language = "English (US)",
volume = "400",
pages = "104--109",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Brief and cost-effective tool for assessing verbal learning in multiple sclerosis

T2 - Comparison of the Rey Auditory Verbal Learning Test (RAVLT) to the California Verbal Learning Test – II (CVLT-II)

AU - Beier, Meghan

AU - Hughes, Abbey

AU - Williams, Michael W.

AU - Gromisch, Elizabeth S.

PY - 2019/5/15

Y1 - 2019/5/15

N2 - Background: The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is a common cognitive screening tool. However, administration and scoring can be time-consuming, and its use of proprietary subtests like the California Verbal Learning Test – II (CVLT-II) is financially limiting. Use of the non-proprietary Rey Auditory Verbal Learning Test (RAVLT) may be provide a valid alternative. Objectives: To compare the RAVLT and CVLT-II in terms of diagnostic accuracy for detecting cognitive impairment, and to determine optimal cut-scores for the RAVLT. Methods: 100 participants with MS completed the five learning trials from the RAVLT and CVLT-II. Receiver operating characteristic analyses were used to compare the measures’ sensitivities, specificities, positive predictive values (PPV) and negative predictive values (NPV), and to identify optimal cut-scores. Results: Using a criterion of 1.5 SD below the normative sample mean, the RAVLT showed fair to good (κs = 0.21–0.41) agreement with the CVLT-II. A cut-score of 12 on Trials 1 + 2 of the RAVLT showed fair sensitivity (75%) and specificity (76%) and did not differ significantly from the CVLT-II (p >.05). Conclusions: Performance on initial learning trials of the RAVLT may provide a brief, valid, and cost-effective alternative to the CVLT-II for screening verbal learning impairments in MS.

AB - Background: The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is a common cognitive screening tool. However, administration and scoring can be time-consuming, and its use of proprietary subtests like the California Verbal Learning Test – II (CVLT-II) is financially limiting. Use of the non-proprietary Rey Auditory Verbal Learning Test (RAVLT) may be provide a valid alternative. Objectives: To compare the RAVLT and CVLT-II in terms of diagnostic accuracy for detecting cognitive impairment, and to determine optimal cut-scores for the RAVLT. Methods: 100 participants with MS completed the five learning trials from the RAVLT and CVLT-II. Receiver operating characteristic analyses were used to compare the measures’ sensitivities, specificities, positive predictive values (PPV) and negative predictive values (NPV), and to identify optimal cut-scores. Results: Using a criterion of 1.5 SD below the normative sample mean, the RAVLT showed fair to good (κs = 0.21–0.41) agreement with the CVLT-II. A cut-score of 12 on Trials 1 + 2 of the RAVLT showed fair sensitivity (75%) and specificity (76%) and did not differ significantly from the CVLT-II (p >.05). Conclusions: Performance on initial learning trials of the RAVLT may provide a brief, valid, and cost-effective alternative to the CVLT-II for screening verbal learning impairments in MS.

KW - Cognitive dysfunction

KW - Cut scores

KW - Multiple sclerosis

KW - Neuropsychological tests

UR - http://www.scopus.com/inward/record.url?scp=85063261947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063261947&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2019.03.016

DO - 10.1016/j.jns.2019.03.016

M3 - Article

VL - 400

SP - 104

EP - 109

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -